16/08/2025
“New Era of Healthcare: BIDE Launches Advanced Multidisciplinary Facility”
Karachi, 14 August 2025 — The Baqai Institute of Diabetology and Endocrinology (BIDE) formally inaugurated its newly established hospital facility, the Multidisciplinary Clinic, comprising 15 purpose-built clinics staffed by more than 30 consultants representing a wide range of medical specialties.
The inauguration ceremony was attended by a distinguished gathering of stakeholders, including senior representatives from the pharmaceutical industry — among them the Chief Executive Officers of ATCO Pharma, Pharmevo, Maxitech, Horizon, and the General Managers of Novo Nordisk Pakistan, Hoechst Pakistan, Martin Dow, as well as senior representatives of Getz, Cell Laboratories, and Highnoon Pharma. The event was further graced by the presence of government officials, including the ADC Central, SP, DSP Central, DHO, and the Additional Director of Health.
The highlight of the occasion was the ribbon-cutting ceremony, performed by Mrs. Fiza Baqai, symbolizing the formal commencement of this new phase in BIDE’s ongoing commitment to advancing healthcare in Pakistan.
In her address, Mrs. Baqai emphasized the broader vision behind the project, stating:
“This new hospital is more than just a building — it represents a promise of hope, healing, and care for all. Our commitment is to make a meaningful and lasting difference in people’s lives.”
Industry leaders also expressed their appreciation for BIDE’s role in enhancing healthcare delivery. The CEO of ATCO Pharma extended his congratulations, reaffirming the company’s support for initiatives that strengthen healthcare infrastructure in Pakistan:
“We are honored to be part of this important initiative. At ATCO Pharma, we believe in empowering institutions that share our vision for accessible and quality healthcare.”
Similarly, the CEO of Pharmevo highlighted the importance of BIDE’s contributions to diabetes and endocrinology care in the country:
“Our partnership with BIDE reflects a shared mission to bring innovation, education, and improved patient outcomes to the forefront of healthcare.”
Representatives from Novo Nordisk further acknowledged BIDE’s pioneering role in clinical research, patient education, and therapeutic innovation, pledging continued collaboration in areas of mutual interest.
The event concluded with a guided tour of the new facility, showcasing its state-of-the-art infrastructure, advanced patient care units, and specialized departments, designed to respond to the evolving healthcare needs of the community.
This milestone underscores BIDE’s enduring commitment to innovation, compassion, and excellence in medical services, and reaffirms its role as a leading institution in advancing the standards of healthcare across Pakistan.
